Clinical Social Workers in Salem, UT Accepting Medicare

7 Clinical Social Workers found. Showing 1 - 7

Norman Douglas Huff Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 376 E 700 S, Salem, UT 84653 Phone: 801-423-7836

Julie Gale, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 251 Highway 198 Ste 5, Salem, UT 84653 Phone: 385-422-2322

Candi Higley, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 567 N State Road 198, Salem, UT 84653 Phone: 385-404-5517

Rebecca Garner Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 245 Ut-198 Suite #5, Salem, UT 84653 Phone: 385-208-7701

Jessica Ann Paletta, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 345 N State Road 198, Salem, UT 84653 Phone: 801-423-3000

Jean Nielson, MSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 251 Highway 198, Ste #4, Salem, UT 84653 Phone: 801-609-4504

Lori Marchant, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 245 W Hwy 198 Ste #5, Salem, UT 84653 Phone: 385-208-7701

News Archive

One in three 13 year olds are binge drinking: Study

Some 35% of school pupils drink to excess by their early teenage years, a study has found. The findings came out of a survey of drinking habits in six European countries: Germany, Iceland, Italy, the Netherlands, Poland and Scotland. The study defined binge drinking as consuming five or more alcoholic drinks on one occasion.

Merck, sanofi-aventis enter global cancer research and development agreement

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Merck, has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which Merck Serono and sanofi-aventis U.S. Inc. will collaboratively investigate novel experimental combinations of agents that could block specific pathways in cancer cells. This collaboration could deliver novel targeted oncology treatments with high therapeutic potential.

Combination of HUCBCs and Simvastatin offers promising therapy for stroke: Study

Researchers at the Henry Ford Health System (Detroit, MI) and colleagues at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, have found that when human umbilical cord blood cells were transplanted into test rats modeled with stroke, the addition of Simvastatin to the HUCBCs significantly increased the therapeutic benefit of the HUCBCs.

Important new findings on T cell immunity in COVID-19

Researchers at the Karolinska University Hospital and University Hospital of Wales report that people who have recovered from asymptomatic or mild cases of coronavirus disease 2019 (COVID-19) may have long-term T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

ActiveSite's ASP-440 plasma kallikrein inhibitor effective in reducing diabetes-induced blood-retinal barrier breakdown

ActiveSite Pharmaceuticals, Inc., announced today the online publication of a study in the journal Diabetes that describes the effectiveness of its novel plasma kallikrein inhibitor ASP-440 in reducing blood-retinal barrier breakdown in a rodent model of diabetes.

Read more Medical News

› Verified 1 days ago